nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—muscle cancer	0.83	1	CbGaD
Risedronate—PTGS2—Etoposide—muscle cancer	0.0564	1	CbGbCtD
Risedronate—PTGS2—hindlimb—muscle cancer	0.00373	0.145	CbGeAlD
Risedronate—PTGS2—appendage—muscle cancer	0.0032	0.125	CbGeAlD
Risedronate—FDPS—smooth muscle tissue—muscle cancer	0.00218	0.085	CbGeAlD
Risedronate—FDPS—renal system—muscle cancer	0.0021	0.0818	CbGeAlD
Risedronate—FDPS—cardiac atrium—muscle cancer	0.00188	0.0733	CbGeAlD
Risedronate—FDPS—tendon—muscle cancer	0.00164	0.0638	CbGeAlD
Risedronate—FDPS—bone marrow—muscle cancer	0.00158	0.0618	CbGeAlD
Risedronate—FDPS—vagina—muscle cancer	0.00152	0.0592	CbGeAlD
Risedronate—FDPS—head—muscle cancer	0.0014	0.0547	CbGeAlD
Risedronate—FDPS—testis—muscle cancer	0.00135	0.0529	CbGeAlD
Risedronate—PTGS2—embryo—muscle cancer	0.00106	0.0414	CbGeAlD
Risedronate—PTGS2—smooth muscle tissue—muscle cancer	0.000835	0.0326	CbGeAlD
Risedronate—PTGS2—renal system—muscle cancer	0.000803	0.0314	CbGeAlD
Risedronate—PTGS2—tendon—muscle cancer	0.000627	0.0245	CbGeAlD
Risedronate—PTGS2—bone marrow—muscle cancer	0.000607	0.0237	CbGeAlD
Risedronate—PTGS2—vagina—muscle cancer	0.000582	0.0227	CbGeAlD
Risedronate—PTGS2—head—muscle cancer	0.000538	0.021	CbGeAlD
Risedronate—Cardiac disorder—Vincristine—muscle cancer	0.000425	0.00484	CcSEcCtD
Risedronate—Bone disorder—Doxorubicin—muscle cancer	0.000425	0.00483	CcSEcCtD
Risedronate—Arthropathy—Doxorubicin—muscle cancer	0.000422	0.0048	CcSEcCtD
Risedronate—Hypocalcaemia—Doxorubicin—muscle cancer	0.000419	0.00476	CcSEcCtD
Risedronate—Cough increased—Doxorubicin—muscle cancer	0.000419	0.00476	CcSEcCtD
Risedronate—Glossitis—Doxorubicin—muscle cancer	0.000416	0.00473	CcSEcCtD
Risedronate—Pneumonia—Etoposide—muscle cancer	0.000416	0.00473	CcSEcCtD
Risedronate—Angiopathy—Vincristine—muscle cancer	0.000416	0.00473	CcSEcCtD
Risedronate—Infestation NOS—Etoposide—muscle cancer	0.000414	0.0047	CcSEcCtD
Risedronate—Infestation—Etoposide—muscle cancer	0.000414	0.0047	CcSEcCtD
Risedronate—Mediastinal disorder—Vincristine—muscle cancer	0.000413	0.0047	CcSEcCtD
Risedronate—Anaemia—Dactinomycin—muscle cancer	0.000413	0.00469	CcSEcCtD
Risedronate—Ulcer—Doxorubicin—muscle cancer	0.000406	0.00461	CcSEcCtD
Risedronate—Mental disorder—Vincristine—muscle cancer	0.000402	0.00457	CcSEcCtD
Risedronate—Ecchymosis—Methotrexate—muscle cancer	0.000401	0.00455	CcSEcCtD
Risedronate—Neoplasm—Methotrexate—muscle cancer	0.000401	0.00455	CcSEcCtD
Risedronate—Bladder pain—Methotrexate—muscle cancer	0.000401	0.00455	CcSEcCtD
Risedronate—Bone pain—Doxorubicin—muscle cancer	0.0004	0.00455	CcSEcCtD
Risedronate—Inflammation—Doxorubicin—muscle cancer	0.000395	0.0045	CcSEcCtD
Risedronate—Hepatobiliary disease—Etoposide—muscle cancer	0.000391	0.00445	CcSEcCtD
Risedronate—Neck pain—Doxorubicin—muscle cancer	0.000388	0.00441	CcSEcCtD
Risedronate—Musculoskeletal pain—Doxorubicin—muscle cancer	0.000388	0.00441	CcSEcCtD
Risedronate—Back pain—Vincristine—muscle cancer	0.000386	0.00439	CcSEcCtD
Risedronate—Myalgia—Dactinomycin—muscle cancer	0.00038	0.00432	CcSEcCtD
Risedronate—Eructation—Doxorubicin—muscle cancer	0.000377	0.00429	CcSEcCtD
Risedronate—Cystitis noninfective—Doxorubicin—muscle cancer	0.000375	0.00426	CcSEcCtD
Risedronate—Influenza like illness—Doxorubicin—muscle cancer	0.000373	0.00424	CcSEcCtD
Risedronate—Cystitis—Doxorubicin—muscle cancer	0.00037	0.00421	CcSEcCtD
Risedronate—Anaemia—Vincristine—muscle cancer	0.000369	0.00419	CcSEcCtD
Risedronate—Colitis—Doxorubicin—muscle cancer	0.000368	0.00419	CcSEcCtD
Risedronate—Urinary tract disorder—Etoposide—muscle cancer	0.000367	0.00417	CcSEcCtD
Risedronate—Urethral disorder—Etoposide—muscle cancer	0.000364	0.00414	CcSEcCtD
Risedronate—Infection—Dactinomycin—muscle cancer	0.000362	0.00412	CcSEcCtD
Risedronate—Vertigo—Vincristine—muscle cancer	0.000359	0.00408	CcSEcCtD
Risedronate—Dry eye—Doxorubicin—muscle cancer	0.000354	0.00403	CcSEcCtD
Risedronate—Cramps of lower extremities—Doxorubicin—muscle cancer	0.000352	0.00401	CcSEcCtD
Risedronate—Oesophagitis—Doxorubicin—muscle cancer	0.000351	0.00399	CcSEcCtD
Risedronate—Eye disorder—Etoposide—muscle cancer	0.000347	0.00395	CcSEcCtD
Risedronate—Neoplasm—Doxorubicin—muscle cancer	0.000347	0.00394	CcSEcCtD
Risedronate—Bladder pain—Doxorubicin—muscle cancer	0.000347	0.00394	CcSEcCtD
Risedronate—Ecchymosis—Doxorubicin—muscle cancer	0.000347	0.00394	CcSEcCtD
Risedronate—Cardiac disorder—Etoposide—muscle cancer	0.000345	0.00392	CcSEcCtD
Risedronate—Hypertension—Vincristine—muscle cancer	0.000345	0.00392	CcSEcCtD
Risedronate—Myalgia—Vincristine—muscle cancer	0.00034	0.00386	CcSEcCtD
Risedronate—Angiopathy—Etoposide—muscle cancer	0.000337	0.00383	CcSEcCtD
Risedronate—Hypertonia—Doxorubicin—muscle cancer	0.000336	0.00382	CcSEcCtD
Risedronate—Immune system disorder—Etoposide—muscle cancer	0.000335	0.00381	CcSEcCtD
Risedronate—Mediastinal disorder—Etoposide—muscle cancer	0.000335	0.00381	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000332	0.00378	CcSEcCtD
Risedronate—Infection—Vincristine—muscle cancer	0.000324	0.00368	CcSEcCtD
Risedronate—Osteoarthritis—Methotrexate—muscle cancer	0.000322	0.00366	CcSEcCtD
Risedronate—Nervous system disorder—Vincristine—muscle cancer	0.000319	0.00363	CcSEcCtD
Risedronate—Fatigue—Dactinomycin—muscle cancer	0.000314	0.00357	CcSEcCtD
Risedronate—Back pain—Etoposide—muscle cancer	0.000313	0.00356	CcSEcCtD
Risedronate—Pain—Dactinomycin—muscle cancer	0.000312	0.00355	CcSEcCtD
Risedronate—Muscle spasms—Etoposide—muscle cancer	0.000311	0.00353	CcSEcCtD
Risedronate—Anaemia—Etoposide—muscle cancer	0.000299	0.0034	CcSEcCtD
Risedronate—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000298	0.00339	CcSEcCtD
Risedronate—Liver function test abnormal—Methotrexate—muscle cancer	0.000297	0.00338	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000297	0.00337	CcSEcCtD
Risedronate—Insomnia—Vincristine—muscle cancer	0.000295	0.00335	CcSEcCtD
Risedronate—Paraesthesia—Vincristine—muscle cancer	0.000292	0.00333	CcSEcCtD
Risedronate—Breast disorder—Methotrexate—muscle cancer	0.000291	0.0033	CcSEcCtD
Risedronate—Vertigo—Etoposide—muscle cancer	0.00029	0.0033	CcSEcCtD
Risedronate—Abdominal pain—Dactinomycin—muscle cancer	0.000288	0.00328	CcSEcCtD
Risedronate—Body temperature increased—Dactinomycin—muscle cancer	0.000288	0.00328	CcSEcCtD
Risedronate—Loss of consciousness—Etoposide—muscle cancer	0.000284	0.00323	CcSEcCtD
Risedronate—Cough—Etoposide—muscle cancer	0.000282	0.00321	CcSEcCtD
Risedronate—Gastrointestinal disorder—Vincristine—muscle cancer	0.000281	0.0032	CcSEcCtD
Risedronate—Fatigue—Vincristine—muscle cancer	0.000281	0.00319	CcSEcCtD
Risedronate—Hypertension—Etoposide—muscle cancer	0.000279	0.00317	CcSEcCtD
Risedronate—Constipation—Vincristine—muscle cancer	0.000279	0.00317	CcSEcCtD
Risedronate—Pain—Vincristine—muscle cancer	0.000279	0.00317	CcSEcCtD
Risedronate—Pain in extremity—Doxorubicin—muscle cancer	0.000278	0.00317	CcSEcCtD
Risedronate—Osteoarthritis—Doxorubicin—muscle cancer	0.000278	0.00317	CcSEcCtD
Risedronate—Asthma—Methotrexate—muscle cancer	0.000278	0.00316	CcSEcCtD
Risedronate—Chest pain—Etoposide—muscle cancer	0.000275	0.00313	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000273	0.00311	CcSEcCtD
Risedronate—Hypersensitivity—Dactinomycin—muscle cancer	0.000269	0.00305	CcSEcCtD
Risedronate—Abdominal discomfort—Methotrexate—muscle cancer	0.000266	0.00303	CcSEcCtD
Risedronate—Gastrointestinal pain—Vincristine—muscle cancer	0.000266	0.00303	CcSEcCtD
Risedronate—Infection—Etoposide—muscle cancer	0.000262	0.00298	CcSEcCtD
Risedronate—Asthenia—Dactinomycin—muscle cancer	0.000262	0.00297	CcSEcCtD
Risedronate—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000258	0.00294	CcSEcCtD
Risedronate—Abdominal pain—Vincristine—muscle cancer	0.000257	0.00293	CcSEcCtD
Risedronate—Body temperature increased—Vincristine—muscle cancer	0.000257	0.00293	CcSEcCtD
Risedronate—Liver function test abnormal—Doxorubicin—muscle cancer	0.000257	0.00292	CcSEcCtD
Risedronate—Skin disorder—Etoposide—muscle cancer	0.000256	0.00291	CcSEcCtD
Risedronate—Abdominal pain upper—Doxorubicin—muscle cancer	0.000254	0.00289	CcSEcCtD
Risedronate—Breast disorder—Doxorubicin—muscle cancer	0.000252	0.00286	CcSEcCtD
Risedronate—Diarrhoea—Dactinomycin—muscle cancer	0.000249	0.00284	CcSEcCtD
Risedronate—Pneumonia—Methotrexate—muscle cancer	0.000249	0.00283	CcSEcCtD
Risedronate—Nasopharyngitis—Doxorubicin—muscle cancer	0.000249	0.00283	CcSEcCtD
Risedronate—Infestation NOS—Methotrexate—muscle cancer	0.000248	0.00282	CcSEcCtD
Risedronate—Infestation—Methotrexate—muscle cancer	0.000248	0.00282	CcSEcCtD
Risedronate—Depression—Methotrexate—muscle cancer	0.000247	0.00281	CcSEcCtD
Risedronate—Gastritis—Doxorubicin—muscle cancer	0.000246	0.0028	CcSEcCtD
Risedronate—Muscular weakness—Doxorubicin—muscle cancer	0.000246	0.00279	CcSEcCtD
Risedronate—Abdominal distension—Doxorubicin—muscle cancer	0.000242	0.00275	CcSEcCtD
Risedronate—Conjunctivitis—Methotrexate—muscle cancer	0.000241	0.00274	CcSEcCtD
Risedronate—Influenza—Doxorubicin—muscle cancer	0.000241	0.00274	CcSEcCtD
Risedronate—Asthma—Doxorubicin—muscle cancer	0.000241	0.00274	CcSEcCtD
Risedronate—Hypersensitivity—Vincristine—muscle cancer	0.00024	0.00273	CcSEcCtD
Risedronate—Paraesthesia—Etoposide—muscle cancer	0.000237	0.00269	CcSEcCtD
Risedronate—Dyspnoea—Etoposide—muscle cancer	0.000235	0.00267	CcSEcCtD
Risedronate—Angina pectoris—Doxorubicin—muscle cancer	0.000234	0.00267	CcSEcCtD
Risedronate—Hepatobiliary disease—Methotrexate—muscle cancer	0.000234	0.00267	CcSEcCtD
Risedronate—Asthenia—Vincristine—muscle cancer	0.000234	0.00266	CcSEcCtD
Risedronate—Vomiting—Dactinomycin—muscle cancer	0.000232	0.00264	CcSEcCtD
Risedronate—Bronchitis—Doxorubicin—muscle cancer	0.000231	0.00263	CcSEcCtD
Risedronate—Rash—Dactinomycin—muscle cancer	0.00023	0.00261	CcSEcCtD
Risedronate—Gastrointestinal disorder—Etoposide—muscle cancer	0.000228	0.00259	CcSEcCtD
Risedronate—Fatigue—Etoposide—muscle cancer	0.000227	0.00259	CcSEcCtD
Risedronate—Constipation—Etoposide—muscle cancer	0.000226	0.00257	CcSEcCtD
Risedronate—Pain—Etoposide—muscle cancer	0.000226	0.00257	CcSEcCtD
Risedronate—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000224	0.00254	CcSEcCtD
Risedronate—Haemoglobin—Methotrexate—muscle cancer	0.000224	0.00254	CcSEcCtD
Risedronate—Diarrhoea—Vincristine—muscle cancer	0.000223	0.00253	CcSEcCtD
Risedronate—Haemorrhage—Methotrexate—muscle cancer	0.000222	0.00253	CcSEcCtD
Risedronate—Pharyngitis—Methotrexate—muscle cancer	0.000221	0.00251	CcSEcCtD
Risedronate—Urinary tract disorder—Methotrexate—muscle cancer	0.00022	0.0025	CcSEcCtD
Risedronate—Urethral disorder—Methotrexate—muscle cancer	0.000218	0.00248	CcSEcCtD
Risedronate—Nausea—Dactinomycin—muscle cancer	0.000217	0.00246	CcSEcCtD
Risedronate—Pneumonia—Doxorubicin—muscle cancer	0.000216	0.00245	CcSEcCtD
Risedronate—Gastrointestinal pain—Etoposide—muscle cancer	0.000216	0.00245	CcSEcCtD
Risedronate—Dizziness—Vincristine—muscle cancer	0.000215	0.00245	CcSEcCtD
Risedronate—Infestation—Doxorubicin—muscle cancer	0.000215	0.00244	CcSEcCtD
Risedronate—Infestation NOS—Doxorubicin—muscle cancer	0.000215	0.00244	CcSEcCtD
Risedronate—Urticaria—Etoposide—muscle cancer	0.00021	0.00238	CcSEcCtD
Risedronate—Abdominal pain—Etoposide—muscle cancer	0.000209	0.00237	CcSEcCtD
Risedronate—Body temperature increased—Etoposide—muscle cancer	0.000209	0.00237	CcSEcCtD
Risedronate—Conjunctivitis—Doxorubicin—muscle cancer	0.000209	0.00237	CcSEcCtD
Risedronate—Urinary tract infection—Doxorubicin—muscle cancer	0.000209	0.00237	CcSEcCtD
Risedronate—Eye disorder—Methotrexate—muscle cancer	0.000208	0.00236	CcSEcCtD
Risedronate—Tinnitus—Methotrexate—muscle cancer	0.000207	0.00236	CcSEcCtD
Risedronate—Vomiting—Vincristine—muscle cancer	0.000207	0.00235	CcSEcCtD
Risedronate—Cardiac disorder—Methotrexate—muscle cancer	0.000206	0.00235	CcSEcCtD
Risedronate—Rash—Vincristine—muscle cancer	0.000205	0.00234	CcSEcCtD
Risedronate—Dermatitis—Vincristine—muscle cancer	0.000205	0.00233	CcSEcCtD
Risedronate—Headache—Vincristine—muscle cancer	0.000204	0.00232	CcSEcCtD
Risedronate—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000203	0.00231	CcSEcCtD
Risedronate—Angiopathy—Methotrexate—muscle cancer	0.000202	0.0023	CcSEcCtD
Risedronate—Sinusitis—Doxorubicin—muscle cancer	0.000201	0.00229	CcSEcCtD
Risedronate—Immune system disorder—Methotrexate—muscle cancer	0.000201	0.00228	CcSEcCtD
Risedronate—Mediastinal disorder—Methotrexate—muscle cancer	0.0002	0.00228	CcSEcCtD
Risedronate—Mental disorder—Methotrexate—muscle cancer	0.000195	0.00222	CcSEcCtD
Risedronate—Hypersensitivity—Etoposide—muscle cancer	0.000194	0.00221	CcSEcCtD
Risedronate—Malnutrition—Methotrexate—muscle cancer	0.000194	0.0022	CcSEcCtD
Risedronate—Haemoglobin—Doxorubicin—muscle cancer	0.000194	0.0022	CcSEcCtD
Risedronate—Nausea—Vincristine—muscle cancer	0.000193	0.0022	CcSEcCtD
Risedronate—Rhinitis—Doxorubicin—muscle cancer	0.000193	0.0022	CcSEcCtD
Risedronate—Haemorrhage—Doxorubicin—muscle cancer	0.000193	0.00219	CcSEcCtD
Risedronate—Pharyngitis—Doxorubicin—muscle cancer	0.000191	0.00217	CcSEcCtD
Risedronate—Urinary tract disorder—Doxorubicin—muscle cancer	0.00019	0.00216	CcSEcCtD
Risedronate—Oedema peripheral—Doxorubicin—muscle cancer	0.00019	0.00216	CcSEcCtD
Risedronate—Asthenia—Etoposide—muscle cancer	0.000189	0.00215	CcSEcCtD
Risedronate—Connective tissue disorder—Doxorubicin—muscle cancer	0.000189	0.00215	CcSEcCtD
Risedronate—Urethral disorder—Doxorubicin—muscle cancer	0.000189	0.00215	CcSEcCtD
Risedronate—Back pain—Methotrexate—muscle cancer	0.000187	0.00213	CcSEcCtD
Risedronate—Pruritus—Etoposide—muscle cancer	0.000187	0.00212	CcSEcCtD
Risedronate—Diarrhoea—Etoposide—muscle cancer	0.000181	0.00205	CcSEcCtD
Risedronate—Eye disorder—Doxorubicin—muscle cancer	0.00018	0.00205	CcSEcCtD
Risedronate—Tinnitus—Doxorubicin—muscle cancer	0.00018	0.00204	CcSEcCtD
Risedronate—Anaemia—Methotrexate—muscle cancer	0.000179	0.00204	CcSEcCtD
Risedronate—Cardiac disorder—Doxorubicin—muscle cancer	0.000179	0.00203	CcSEcCtD
Risedronate—Angiopathy—Doxorubicin—muscle cancer	0.000175	0.00199	CcSEcCtD
Risedronate—Dizziness—Etoposide—muscle cancer	0.000174	0.00198	CcSEcCtD
Risedronate—Immune system disorder—Doxorubicin—muscle cancer	0.000174	0.00198	CcSEcCtD
Risedronate—Vertigo—Methotrexate—muscle cancer	0.000174	0.00198	CcSEcCtD
Risedronate—Mediastinal disorder—Doxorubicin—muscle cancer	0.000174	0.00197	CcSEcCtD
Risedronate—Arrhythmia—Doxorubicin—muscle cancer	0.000172	0.00196	CcSEcCtD
Risedronate—Cough—Methotrexate—muscle cancer	0.000169	0.00192	CcSEcCtD
Risedronate—Mental disorder—Doxorubicin—muscle cancer	0.000169	0.00192	CcSEcCtD
Risedronate—Vomiting—Etoposide—muscle cancer	0.000168	0.00191	CcSEcCtD
Risedronate—Malnutrition—Doxorubicin—muscle cancer	0.000168	0.00191	CcSEcCtD
Risedronate—Rash—Etoposide—muscle cancer	0.000166	0.00189	CcSEcCtD
Risedronate—Dermatitis—Etoposide—muscle cancer	0.000166	0.00189	CcSEcCtD
Risedronate—Headache—Etoposide—muscle cancer	0.000165	0.00188	CcSEcCtD
Risedronate—Flatulence—Doxorubicin—muscle cancer	0.000165	0.00188	CcSEcCtD
Risedronate—Arthralgia—Methotrexate—muscle cancer	0.000165	0.00187	CcSEcCtD
Risedronate—Chest pain—Methotrexate—muscle cancer	0.000165	0.00187	CcSEcCtD
Risedronate—Myalgia—Methotrexate—muscle cancer	0.000165	0.00187	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000164	0.00186	CcSEcCtD
Risedronate—Back pain—Doxorubicin—muscle cancer	0.000162	0.00184	CcSEcCtD
Risedronate—Muscle spasms—Doxorubicin—muscle cancer	0.000161	0.00183	CcSEcCtD
Risedronate—Infection—Methotrexate—muscle cancer	0.000157	0.00179	CcSEcCtD
Risedronate—Nausea—Etoposide—muscle cancer	0.000157	0.00178	CcSEcCtD
Risedronate—Nervous system disorder—Methotrexate—muscle cancer	0.000155	0.00176	CcSEcCtD
Risedronate—Anaemia—Doxorubicin—muscle cancer	0.000155	0.00176	CcSEcCtD
Risedronate—Skin disorder—Methotrexate—muscle cancer	0.000154	0.00175	CcSEcCtD
Risedronate—Vertigo—Doxorubicin—muscle cancer	0.000151	0.00171	CcSEcCtD
Risedronate—Syncope—Doxorubicin—muscle cancer	0.00015	0.00171	CcSEcCtD
Risedronate—Loss of consciousness—Doxorubicin—muscle cancer	0.000147	0.00168	CcSEcCtD
Risedronate—Cough—Doxorubicin—muscle cancer	0.000146	0.00166	CcSEcCtD
Risedronate—Hypertension—Doxorubicin—muscle cancer	0.000145	0.00165	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000144	0.00164	CcSEcCtD
Risedronate—Insomnia—Methotrexate—muscle cancer	0.000143	0.00163	CcSEcCtD
Risedronate—Myalgia—Doxorubicin—muscle cancer	0.000143	0.00162	CcSEcCtD
Risedronate—Arthralgia—Doxorubicin—muscle cancer	0.000143	0.00162	CcSEcCtD
Risedronate—Chest pain—Doxorubicin—muscle cancer	0.000143	0.00162	CcSEcCtD
Risedronate—Anxiety—Doxorubicin—muscle cancer	0.000142	0.00162	CcSEcCtD
Risedronate—Paraesthesia—Methotrexate—muscle cancer	0.000142	0.00161	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000142	0.00161	CcSEcCtD
Risedronate—Dyspnoea—Methotrexate—muscle cancer	0.000141	0.0016	CcSEcCtD
Risedronate—Dry mouth—Doxorubicin—muscle cancer	0.00014	0.00159	CcSEcCtD
Risedronate—Dyspepsia—Methotrexate—muscle cancer	0.000139	0.00158	CcSEcCtD
Risedronate—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000136	0.00155	CcSEcCtD
Risedronate—Fatigue—Methotrexate—muscle cancer	0.000136	0.00155	CcSEcCtD
Risedronate—Infection—Doxorubicin—muscle cancer	0.000136	0.00155	CcSEcCtD
Risedronate—Pain—Methotrexate—muscle cancer	0.000135	0.00154	CcSEcCtD
Risedronate—Shock—Doxorubicin—muscle cancer	0.000135	0.00153	CcSEcCtD
Risedronate—Nervous system disorder—Doxorubicin—muscle cancer	0.000134	0.00153	CcSEcCtD
Risedronate—Skin disorder—Doxorubicin—muscle cancer	0.000133	0.00151	CcSEcCtD
Risedronate—Gastrointestinal pain—Methotrexate—muscle cancer	0.000129	0.00147	CcSEcCtD
Risedronate—Urticaria—Methotrexate—muscle cancer	0.000126	0.00143	CcSEcCtD
Risedronate—Abdominal pain—Methotrexate—muscle cancer	0.000125	0.00142	CcSEcCtD
Risedronate—Body temperature increased—Methotrexate—muscle cancer	0.000125	0.00142	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000125	0.00142	CcSEcCtD
Risedronate—Insomnia—Doxorubicin—muscle cancer	0.000124	0.00141	CcSEcCtD
Risedronate—Paraesthesia—Doxorubicin—muscle cancer	0.000123	0.0014	CcSEcCtD
Risedronate—Dyspnoea—Doxorubicin—muscle cancer	0.000122	0.00139	CcSEcCtD
Risedronate—Dyspepsia—Doxorubicin—muscle cancer	0.00012	0.00137	CcSEcCtD
Risedronate—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000118	0.00134	CcSEcCtD
Risedronate—Fatigue—Doxorubicin—muscle cancer	0.000118	0.00134	CcSEcCtD
Risedronate—Pain—Doxorubicin—muscle cancer	0.000117	0.00133	CcSEcCtD
Risedronate—Constipation—Doxorubicin—muscle cancer	0.000117	0.00133	CcSEcCtD
Risedronate—Hypersensitivity—Methotrexate—muscle cancer	0.000116	0.00132	CcSEcCtD
Risedronate—Asthenia—Methotrexate—muscle cancer	0.000113	0.00129	CcSEcCtD
Risedronate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000112	0.00127	CcSEcCtD
Risedronate—Pruritus—Methotrexate—muscle cancer	0.000112	0.00127	CcSEcCtD
Risedronate—Urticaria—Doxorubicin—muscle cancer	0.000109	0.00124	CcSEcCtD
Risedronate—Body temperature increased—Doxorubicin—muscle cancer	0.000108	0.00123	CcSEcCtD
Risedronate—Abdominal pain—Doxorubicin—muscle cancer	0.000108	0.00123	CcSEcCtD
Risedronate—Diarrhoea—Methotrexate—muscle cancer	0.000108	0.00123	CcSEcCtD
Risedronate—Dizziness—Methotrexate—muscle cancer	0.000105	0.00119	CcSEcCtD
Risedronate—Hypersensitivity—Doxorubicin—muscle cancer	0.000101	0.00115	CcSEcCtD
Risedronate—Vomiting—Methotrexate—muscle cancer	0.0001	0.00114	CcSEcCtD
Risedronate—Rash—Methotrexate—muscle cancer	9.97e-05	0.00113	CcSEcCtD
Risedronate—Dermatitis—Methotrexate—muscle cancer	9.96e-05	0.00113	CcSEcCtD
Risedronate—Headache—Methotrexate—muscle cancer	9.9e-05	0.00113	CcSEcCtD
Risedronate—Asthenia—Doxorubicin—muscle cancer	9.82e-05	0.00112	CcSEcCtD
Risedronate—Pruritus—Doxorubicin—muscle cancer	9.68e-05	0.0011	CcSEcCtD
Risedronate—Nausea—Methotrexate—muscle cancer	9.39e-05	0.00107	CcSEcCtD
Risedronate—Diarrhoea—Doxorubicin—muscle cancer	9.36e-05	0.00106	CcSEcCtD
Risedronate—Dizziness—Doxorubicin—muscle cancer	9.05e-05	0.00103	CcSEcCtD
Risedronate—Vomiting—Doxorubicin—muscle cancer	8.7e-05	0.000989	CcSEcCtD
Risedronate—Rash—Doxorubicin—muscle cancer	8.63e-05	0.000981	CcSEcCtD
Risedronate—Dermatitis—Doxorubicin—muscle cancer	8.62e-05	0.00098	CcSEcCtD
Risedronate—Headache—Doxorubicin—muscle cancer	8.57e-05	0.000975	CcSEcCtD
Risedronate—Nausea—Doxorubicin—muscle cancer	8.13e-05	0.000924	CcSEcCtD
